Bennett Lawrence Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.33M Sell
7,445
-17,615
-70% -$5.24M 0.75% 51
2015
Q3
$6.81M Sell
25,060
-1,905
-7% -$585K 2.17% 17
2015
Q2
$8.18M Sell
26,965
-540
-2% -$161K 2.15% 14
2015
Q1
$8.19M Sell
27,505
-660
-2% -$188K 2.18% 16
2014
Q4
$7.25M Sell
28,165
-12,513
-31% -$3.13M 1.95% 19
2014
Q3
$9.81M Buy
40,678
+2,103
+5% +$471K 2.23% 13
2014
Q2
$8.6M Buy
38,575
+1,515
+4% +$314K 1.51% 26
2014
Q1
$7.63M Buy
+37,060
New +$7.34M 1.13% 35

Other funds holding AGN

Bennett Lawrence Management's AGN Position: Q4 2015 in Review

Bennett Lawrence Management reduced its Allergan plc (AGN) stake by 70% in Q4 2015, selling an estimated $5.24M and leaving 7,445 shares worth $2.33M. The position accounts for 0.75% of the portfolio, ranked #51.

Bennett Lawrence Management first reported a position in AGN in Q1 2014 and has held it in 8 quarters since. The position peaked at $9.81M in Q3 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Bennett Lawrence Management held 7,445 shares of Allergan plc worth $2.33M as of Q4 2015.
  • Bennett Lawrence Management sold 17,615 Allergan plc shares in Q4 2015, an estimated $5.24M.
  • Allergan plc made up 0.75% of Bennett Lawrence Management's portfolio in Q4 2015, its #51 holding.
  • Bennett Lawrence Management first reported a position in Allergan plc in Q1 2014 and has held it in 8 quarters since.
  • Bennett Lawrence Management's Allergan plc position peaked at $9.81M in Q3 2014.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Bennett Lawrence Management's 13F filing for Q4 2015, filed 16 Feb 2016.